Genmab A/S

Genmab A/S Book Value per Share

The Book Value per Share of Genmab A/S (GMAB.CO) as of Sep 30, 2026 is 14.29 USD. In the previous year, Book Value per Share was 89.87 USD — a change of -84.10% (lower).

Book Value per Share

14.29USD

YoY

-84.10%

Last updated:

Book Value per Share of Genmab A/S is 2026 14.29 USD. Book Value per Share of Genmab A/S was 2025 89.87 USD. It decreases by -84.10% lower compared to the previous year.

The Genmab A/S Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
19.63 USD
Jan 1, 2019
34.40 USD
Jan 1, 2020
46.82 USD
Jan 1, 2021
54.35 USD
Jan 1, 2022
66.81 USD
Jan 1, 2023
77.41 USD
Jan 1, 2024
89.87 USD
Jan 1, 2025
14.29 USD
The Genmab A/S Book Value per Share history
YEARBook Value per ShareYoY
14.29USD-84.10%
89.87USD+16.09%
77.41USD+15.86%
66.81USD+22.91%
54.35USD+16.08%
46.82USD+36.11%
34.40USD+75.29%
19.63USD+27.78%
15.36USD+29.95%
11.82USD+38.43%
8.54USD+71.51%
4.98USD—
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Book Value per Share of Genmab A/S is 14.29 USD in 2026.

Book Value per Share of Genmab A/S changed from 89.87 USD to 14.29 USD, representing a -84.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

Balance Sheet — Genmab A/S

All Key Metrics — Genmab A/S